Feedback / Questions
lanifibranor (IVA337) - Inventiva, Hepalys Pharma
https://www.globenewswire.com/news-release/2024/10/30/2972018/0/en/Inventiva-announces-the-positive-recommendation-of-the-fifth-DMC-of-the-NATiV3-Phase-3-clinical-trial-with-lanifibranor-in-patients-with-MASH.html
Oct 30, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next